发明名称 РЕЦЕПТОР ЦИТОКИНА
摘要 There is provided an in vitro method for detecting a viral infection in a sample, wherein the viral infection is selected from the group consisting of: (i) a Hepatitis C viral infection; and (ii) a Hepatitis B viral infection; wherein said method comprises: detecting the level of expression of a polypeptide in the sample, wherein said polypeptide comprises a sequence of amino acid residues that is at least 90% identical to: (i) amino acids 21-223 of SEQ ID NO: 2; (ii) amino acids 21-226 of SEQ ID NO: 2; (iii) amino acids 21-223 of SEQ ID NO: 19; or (iv) amino acids 21-226 of SEQ ID NO: 19; or wherein the polypeptide consists of a sequence of amino acid residues that is at least 90% identical to: (v) amino acids 1-491 of SEQ ID NO: 2; (vi) amino acids 1-520 of SEQ ID NO: 19; or (vii) amino acids 1- 211 of SEQ ID NO: 21; and detecting expression of said polypeptide in a control; and comparing the level of expression of the polypeptide in the sample to the level of the polypeptide in the control; and wherein the level of expression of the polypeptide in the sample is greater than the level of polypeptide in the control.
申请公布号 RU2004133765(A) 申请公布日期 2005.06.27
申请号 RU20040133765 申请日期 2003.04.18
申请人 ЗАЙМОДЖЕНЕТИКС Инк. (US) 发明人 ПРЕСНЕЛЛ Скотт Р. (US);ЗУ Венфенг (US);НОВАК Джули  Э. (US);УИТМОР Теодор И. (US);ГРАНТ Фрэнсис Дж. (US);КИНДСВОГЕЛ Уэйн Р. (US);КЛУКЕР Кевин М. (US)
分类号 C12N15/12;C07H21/04;C07K14/715;C07K16/18;C12N5/00;C12N15/63;C12N15/85;C12P21/02;C12P21/08 主分类号 C12N15/12
代理机构 代理人
主权项
地址